Clinical Trial Update: Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy [Phase 2]

View source ↗

Summary

This Phase 2 trial from Institut Claudius Regaud is recruiting metastatic urothelial bladder cancer patients who have not progressed after first-line systemic t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Bladder Cancer

Snippet

Sponsor: Institut Claudius Regaud | Conditions: Urothelial Bladder Cancer | Phase 2 | Status: RECRUITING